Alten, Rieke
Conaghan, P. G.
Strand, V.
Sullivan, E.
Blackburn, S.
Tian, H.
Gandhi, K.
Jugl, S. M.
Deodhar, A.
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation (na)
Article History
Received: 19 October 2018
Revised: 15 January 2019
Accepted: 21 January 2019
First Online: 4 February 2019
Compliance with ethical standards
:
: RA has received grants or research support from Bristol-Myers Squibb, consulting fees from Bristol-Myers Squibb, Novartis, Pfizer Roche, and Eli Lilly. PGC has received speakers’ bureau or consulting fees from Bristol- Myers Squibb, Pfizer, and Novartis. VS has received grants and/or consulting fees from AbbVie, Amgen, AstraZeneca, BMS, Boehringer Ingelheim, Celltrion, Corrona LLC, Crescendo Bioscience, EMD Serono, F. Hoffmann-La Roche Ltd./Genentech, Inc., GSK, Janssen, Eli Lilly, Merck, Novartis, Pfizer, Regeneron, Samsung, Sandoz, Sanofi, and UCB and has served on advisory boards for AbbVie, Amgen, AstraZeneca, BMS, Celltrion, Crescendo/Myriad Genetics, EMDSerono, Genentech/Roche, GSK, Janssen, Lilly, Novartis, Pfizer, Regeneron, Sandoz, Sanofi, and UCB. AD has received grants or research support from AbbVie, Eli Lilly, GlaxoSmithKline, Janssen, Novartis, Pfizer, and UCB Pharma, and consulting fees from Eli Lilly, Janssen, Novartis, Pfizer, and UCB Pharma. ES and SB are employees of Adelphi Real World; HT and KG are shareholders and employees of Novartis; SJ is a shareholder and employee of Novartis Pharma AG.